Positron emission tomography experience with 2‐[18F]fluoro‐3‐(2(s)‐azetidinylmethoxy)pyridine (2‐[18F]fa) in the living human brain of smokers with paranoid schizophrenia

Utilizing postmortem data (Breese et al. [2000] Neuropsychopharmacology 23:351–364), we hypothesized that the densities of high‐affinity neuronal α4β2 nicotinic acetylcholine receptors (nAChRs) in the brain exist in a continuum from highest to lowest as follows: smokers without schizophrenia > smokers with schizophrenia > nonsmokers without schizophrenia > nonsmokers with schizophrenia. Application of the Kruskal‐Wallis Test (Statacorp, 2003) to the postmortem data (Breese et al. [2000] Neuropsychopharmacology 23:351‐364) confirmed the hypothesized order in the cortex and the hippocampus and attained significance in the caudate and the thalamus. Positron emission tomography (PET) was performed for 60 min at 6 h after the intravenous administration of 444 megabequerels [MBq] (12 mCi) 2‐[18F]fluoro‐3‐(2(S)‐azetidinylmethoxy)pyridine (2‐[18F]FA), a radiotracer for high‐affinity neuronal α4β2 nAChRs, as a bolus plus continuous infusion to 10 adults (seven men and three women) (six smokers including five with paranoid schizophrenia and four nonsmokers) ranging in age from 22 to 56 years (mean 40.1, standard deviation 13.6). The thalamic nondisplaceable binding potential (BPND) was 1.32 ± 0.19 (mean ± standard deviation) for healthy control nonsmokers; 0.50 ± 0.19 for smokers with paranoid schizophrenia; and 0.51 for the single smoker without paranoid schizophrenia. The thalamic BPNDs of nonsmokers were significantly higher than those of smokers who smoked cigarettes a few hours before the scans (P = 0.0105) (StataCorp, 2003), which was likely due to occupancy of nAChRs by inhaled nicotine in smokers. Further research is needed to rule out the effects of confounding variables. Synapse 2012. © 2011Wiley Periodicals, Inc.

[1]  Marianne Patt,et al.  Synthesis procedure for routine production of 2-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[18F]F-A-85380). , 2007, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[2]  James Robert Brašić Documentation of demographic data. , 2003, Psychological Reports.

[3]  Yun Zhou,et al.  Single photon emission computed tomography experience with (S)‐5‐[123I]iodo‐3‐(2‐azetidinylmethoxy)pyridine in the living human brain of smokers and nonsmokers , 2009, Synapse.

[4]  S. Dursun,et al.  Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette's syndrome: an open study , 1997, Psychological Medicine.

[5]  J. Seibyl,et al.  Quantification of Smoking-Induced Occupancy of β2-Nicotinic Acetylcholine Receptors: Estimation of Nondisplaceable Binding , 2010, The Journal of Nuclear Medicine.

[6]  H. Shimizu,et al.  Development of a screening questionnaire for tobacco/nicotine dependence according to ICD-10, DSM-III-R, and DSM-IV. , 1999, Addictive behaviors.

[7]  James Robert Brašić,et al.  Behavioral Effects of Clomipramine on Prepubertal Boys With Autistic Disorder and Severe Mental Retardation , 1998, CNS Spectrums.

[8]  W. Goodman,et al.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. , 1989, Archives of general psychiatry.

[9]  G. Simpson,et al.  A rating scale for tardive dyskinesia , 1979, Psychopharmacology.

[10]  J. Thompson Behavioural Psychotherapy: Maudsley Pocket Book of Clinical Management. , 1992 .

[11]  Yun Zhou,et al.  A New Linear Parametric Imaging Algorithm Derived from a Simplified Reference Tissue Model for Ligand-Receptor Dynamic PET Studies , 2002 .

[12]  Svetlana I. Chefer,et al.  Cigarette Smoking Saturates Brain α4β2 Nicotinic Acetylcholine Receptors , 2006 .

[13]  J. Gault,et al.  Smoking and schizophrenia: abnormal nicotinic receptor expression. , 2000, European journal of pharmacology.

[14]  H. Kuwabara,et al.  Neural Activation During Performance of Number-Letter Sequencing , 2000, Applied neuropsychology.

[15]  Suck-Won Kim,et al.  The Yale-Brown Obsessive-Compulsive Scale: Measures of internal consistency , 1994, Psychiatry Research.

[16]  Mark T. Madsen,et al.  Single Photon Emission Computed Tomography (SPECT) , 2002 .

[17]  D. Cohen,et al.  The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. , 1989, Journal of the American Academy of Child and Adolescent Psychiatry.

[18]  Dc Washington Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .

[19]  M. Kassiou,et al.  Decreased vesicular acetylcholine transporter and α4β2 nicotinic receptor density in the rat brain following 192 IgG-saporin immunolesioning , 2007, Neuroscience Letters.

[20]  Karl J. Friston,et al.  Incorporating Prior Knowledge into Image Registration , 1997, NeuroImage.

[21]  Monique Ernst,et al.  2 [18F]F‐A85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  P. Wender,et al.  The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. , 1993, The American journal of psychiatry.

[23]  A. C. Collins,et al.  Abnormal Regulation of High Affinity Nicotinic Receptors in Subjects with Schizophrenia , 2000, Neuropsychopharmacology.

[24]  R. P. Maguire,et al.  Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  A. Mukhin,et al.  A simplified method for the measurement of nonmetabolized 2-[18F]F-A-85380 in blood plasma using solid-phase extraction. , 2007, Nuclear medicine and biology.

[26]  M. Woerner,et al.  Anchoring the BPRS: an aid to improved reliability. , 1988, Psychopharmacology bulletin.

[27]  M. Thase,et al.  Psychiatric rating scales. , 2012, Handbook of clinical neurology.

[28]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[29]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[30]  Sung-Cheng Huang,et al.  Linear regression with spatial constraint to generate parametric images of ligand-receptor dynamic PET studies with a simplified reference tissue model , 2003, NeuroImage.

[31]  P. Sachdev A rating scale for acute drug-induced akathisia: development, reliability, and validity , 1994, Biological Psychiatry.

[32]  T. Rustin Assessing nicotine dependence. , 2000, American family physician.

[33]  D. Wong,et al.  Column-switching HPLC for the analysis of plasma in PET imaging studies. , 2000, Nuclear medicine and biology.

[34]  M. Denckla,et al.  Revised Neurological Examination for Subtle Signs (1985). , 1985, Psychopharmacology bulletin.

[35]  F. Jessen,et al.  Smoking upregulates α4β2* nicotinic acetylcholine receptors in the human brain , 2008, Neuroscience Letters.

[36]  M. Folstein,et al.  EFFECTS OF AGE ON DOPAMINE AND SEROTONIN RECEPTORS MEASURED BY POSITRON TOMOGRAPHY IN THE LIVING HUMAN BRAIN , 1984, Science.

[37]  Swen Hesse,et al.  Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer’s disease assessed with positron emission tomography , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[38]  A. Rahmim,et al.  The second generation HRRT - a multi-centre scanner performance investigation , 2005, IEEE Nuclear Science Symposium Conference Record, 2005.

[39]  John L. Musachio,et al.  Human [/sup 123/I]5-I-A-85380 dynamic SPECT studies in normals: kinetic analysis and parametric imaging , 2001, 2001 IEEE Nuclear Science Symposium Conference Record (Cat. No.01CH37310).

[40]  J. Overall,et al.  The Brief Psychiatric Rating Scale , 1962 .

[41]  P. Sanberg,et al.  Nicotine for the treatment of Tourette's syndrome. , 1997, Pharmacology & therapeutics.

[42]  M. Goldstein,et al.  Neuropsychiatric assessment. , 2005, The Psychiatric clinics of North America.

[43]  M. Mandelkern,et al.  Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies. , 2005, Nuclear medicine and biology.

[44]  D. Wong,et al.  Clinical Perspective and Recent Development of PET Radioligands for Imaging Cerebral Nicotinic Acetylcholine Receptors. , 2009, PET clinics.

[45]  J. Links,et al.  In Vivo Measurement of Dopamine Receptors in Human Brain by Positron Emission Tomography Age and Sex Differences a , 1988, Annals of the New York Academy of Sciences.

[46]  W. Goodman,et al.  The Yale-Brown Obsessive Compulsive Scale. II. Validity. , 1989, Archives of general psychiatry.

[47]  Sowmyanarayanan Sadagopan,et al.  WWW: service provider , 2002, UBIQ.

[48]  James Robert Brašić Documentation of Ethnicity , 2004, Psychological reports.

[49]  Hiroto Kuwabara,et al.  Development of radioligands with optimized imaging properties for quantification of nicotinic acetylcholine receptors by positron emission tomography. , 2010, Life sciences.

[50]  James Robert Brašić,et al.  Neurodevelopmental hypothesis of schizophrenia: a central sensory disturbance. , 2000, Medical hypotheses.

[51]  R. Conley,et al.  Novel Factor-Based Symptom Scores in Treatment Resistant Schizophrenia: Implications for Clinical Trials , 2002, Neuropsychopharmacology.

[52]  H. Vankova Mini Mental State , 2010 .

[53]  Abnormal Involuntary Movement Scale (AIMS). , 1988, Psychopharmacology bulletin.

[54]  K. Fagerström,et al.  Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders. , 1996, Pharmacology & therapeutics.

[55]  D. V. Jeste,et al.  Tardive dyskinesia. , 1993, Schizophrenia bulletin.

[56]  P. Gillig,et al.  Attention-Deficit/Hyperactivity Disorder in Adults , 2004 .

[57]  James Robert Brašić,et al.  In vivo imaging of neurotransmitter systems in neuropsychiatry , 2001, Clinical Neuroscience Research.

[58]  P. Wender Attention-deficit hyperactivity disorder in adults. , 1995, The Psychiatric clinics of North America.

[59]  T. Barnes A Rating Scale for Drug-Induced Akathisia , 1989, British Journal of Psychiatry.

[60]  Johannes Schwarz,et al.  Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease. , 2009, Archives of general psychiatry.

[61]  J. Ashburner,et al.  Multimodal Image Coregistration and Partitioning—A Unified Framework , 1997, NeuroImage.

[62]  P. Brust,et al.  Measurement of the alpha4beta2* nicotinic acetylcholine receptor ligand 2-[(18)F]Fluoro-A-85380 and its metabolites in human blood during PET investigation: a methodological study. , 2007, Nuclear medicine and biology.

[63]  Dean F. Wong,et al.  Positron emission tomography--a tool for identifying the effects of alcohol dependence on the brain. , 2003 .

[64]  James Robert Brašić,et al.  Brain imaging research: Does the science serve clinical practice? , 2007, International review of psychiatry.

[65]  Henry A. Nasrallah,et al.  Schizophrenia, “Just the Facts” What we know in 2008. 2. Epidemiology and etiology , 2008, Schizophrenia Research.

[66]  James Robert Brašić Treatment of movement disorders in autism spectrum disorders , 2003 .

[67]  H. Kuwabara,et al.  Age-Related Changes in Neural Activation During Working Memory Performance , 2000 .